New insights on better diagnosis and treatment of ischemic cholecystitis

Ischemic cholecystitis is a form of gallbladder inflammation that occurs without gallstones or another form of external compression.

ADA 2024: Altimmune’s GLP-1 drug shows weight loss potential – Pharmaceutical Technology

At the ADA scientific sessions, Altimmune presented data demonstrating significant weight loss in patients who took pemvidutide. Credit: Pavel Kapysh via Shutterstock. Altimmune has taken

June 24, 2024

EC approves TECVAYLI’s reduced dosage for multiple myeloma

Janssen’s Teclistamab is a bispecific antibody directed at B-cell maturation antigen on multiple myeloma cells. Credit: Vysotsky / commons.wikimedia.org. The European Commission (EC) has approved

August 21, 2023

GPT-4 language model gives limited quality medical answers in study

Dive Brief: The successor to ChatGPT delivers answers that agree with health guideline recommendations 60% of the time, but gives low- to moderate-quality information, according

July 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.